MDM : Summary for Mountain Province Diamonds Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 37 mins
Loading...
Loading...
  • PR Newswire3 days ago

    Marapharm to Present at Planet Microcap Showcase in Las Vegas; Update on Nevada

    Marapharm Ventures Inc. ("Marapharm") (MRPHF) (MDM) (2M0.F) is pleased to announce that Marapharm has been invited by the CSE to attend the Planet Microcap Showcase 2017, in Las Vegas on April 26-28. Linda Sampson and Yari Nieken, directors, will represent Marapharm. As an emerging company, Marapharm will participate in one-on-one meetings, networking and will do a presentation to financial professionals, industry leaders, investors and executives.

  • PR Newswire20 days ago

    Marapharm Ventures Inc. ("Marapharm") Completes Independent Valuation of Las Vegas, Nevada, Cannabis Project

    KELOWNA, British Columbia, April 7, 2017 /PRNewswire/ -- Marapharm (CSE: MDM)(OTCQB: MRPHF)(FSE:2M0) is pleased to announce that it has received an independent calculation/valuation report with respect ...

  • PR Newswire24 days ago

    Marapharm Ventures Inc., Kelowna, B.C. ("Marapharm"), Announces a Laboratory for Research and Development of Marijuana for its Washington Property

    Marapharm (MRPHF) (MDM) (2M0.F) is pleased to announce that it has entered into an agreement with AlphaPheno Inc. ("Alpha") of Washington state to build a laboratory on the 13.6-acre-site of Marapharm's property.  Alpha, in conjunction with Veritas Pharma Inc., an emerging discovery and IP development company, will enter into a joint venture arrangement for the research and development ("R&D") business. Alpha holds a Tier 3 cultivation and processing license and therefore is permitted to apply for and hold an R&D license.  With an extensive list of cannabis genetics and existing cultivation space, Alpha is applying for a marijuana research license to leverage the synergy with Veritas in the U.S. market. Veritas will provide the R&D thesis, programs, equipment, and laboratory standards and protocol for a focused R&D approach.  Veritas will also determine the key qualified personnel required to execute these programs.